In our new episode CEO Insights: Immunotherapy innovations, AI challenges and clinical trial observations, our CEO & Founder, Alan Vanderborght, sits down with David Apelian, CEO at Theolytics.
Together, they explore various current industry topics, focusing on exciting immunotherapy innovations, AI pros and cons and clinical trial observations.
Listen Below:
